Sorrento Therapeutics, Inc.

About Sorrento Therapeutics, Inc.

Sorrento Therapeutics is a biopharmaceutical company focused on the development of innovative therapies. While the provided content does not include a detailed mission statement or overview, the structure and links suggest a focus on research and therapeutic solutions.

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debtor-in-Possession T: - FT: Debtor-in-Possession	A: 75000000 MR: - FA: 75 million FAN: 75000000	D: 2023-03-29 FD: 2023-03-29	1 investors
2	RT: Debtor-in-Possession Financing T: - FT: Debtor-in-Possession Financing	A: 75000000 MR: - FA: $75 million FAN: 75000000	D: 2023-02-21 FD: 2023-02-21	1 investors

Debtor-in-Possession Latest

2023-03-29

$75.0M

1 investor (Pro only)

Debtor-in-Possession Financing 2023-02-21

$75.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Henry Ji

Chairman, President and CEO

S

Scott Schaus

Chief Technology Officer

J

John Waldheim

Executive Director, Government Affairs

Recent News